A. muciniphila administration boosted anti-PD-1 efficacy in antibiotic-treated mice [38] and Bifidobacterium administration to mice with melanoma improved response to anti-PD-L1 therapy, nearly abolishing tumor outgrowth [35]. This evidence concerns the gene PDCD1 and melanoma.